UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network, 2022-01, Vol.20 (1), p.71

2022

Volltextzugriff (PDF)

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

Journal of clinical oncology, 2018-10, Vol.36 (28), p.2863-2871

2018

Volltextzugriff (PDF)

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy

Proceedings of the National Academy of Sciences - PNAS, 2019-04, Vol.116 (18), p.9008-9013

2019

Volltextzugriff (PDF)

Synthesis of Calix-Salen Silver Corates for Evaluation of Their Antimicrobial and Anticancer Activities

ACS omega, 2019-12, Vol.4 (25), p.21346-21352

2019

Volltextzugriff (PDF)

Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer

Cancer, 2021-06, Vol.127 (12), p.1965-1973

2021

Volltextzugriff (PDF)

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

Frontiers in oncology, 2020-10, Vol.10, p.581189-581189

2020

Volltextzugriff (PDF)

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

Frontiers in oncology, 2023-04, Vol.13, p.1161089-1161089

2023

Volltextzugriff (PDF)

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Cancer biology & medicine, 2016-03, Vol.13 (1), p.77-86

2016

Volltextzugriff (PDF)

Synthesis of Novel Bis-imino and Bis-amino Curcuminoids for Evaluation of Their Anticancer and Antibacterial Activity

ACS omega, 2022-12, Vol.7 (49), p.45545-45555

2022

Volltextzugriff (PDF)

APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer

Frontiers in oncology, 2022-03, Vol.12, p.816706-816706

2022

Volltextzugriff (PDF)

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002127

2021

Volltextzugriff (PDF)

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

Journal of thoracic oncology, 2015-09, Vol.10 (9), p.e89-e90

2015

Volltextzugriff (PDF)

FGFR Signaling as a Target for Lung Cancer Therapy

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.9-20

2016

Volltextzugriff (PDF)

Metal-free synthesis of calixsalen-type cavitands for the recognition of fluoride ion

Synthetic communications, 2018-02, Vol.48 (3), p.291-301

2018

Volltextzugriff (PDF)

Micellization and clouding behaviour of an ionic surfactant in a deep eutectic solvent: A case of the reline-water mixture

Journal of molecular liquids, 2022-10, Vol.364, p.119991, Article 119991

2022

Volltextzugriff (PDF)

An interplay between spacer nature and alkyl chain length on aqueous micellar properties of cationic Gemini surfactants: A multi-technique approach

Journal of molecular liquids, 2019-03, Vol.278, p.290-298

2019

Volltextzugriff (PDF)

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors

Future oncology (London, England), 2019-07, Vol.15 (20), p.2337-2348

2019

Volltextzugriff (PDF)

Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment

Urologic oncology, 2024-07

2024

Volltextzugriff (PDF)

Calix-salen cavitand as colorimetric chemosensor for Cu2+ and anticancer activity of copper cavitate

Inorganic chemistry communications, 2019-01, Vol.99, p.16-19

2019

Volltextzugriff (PDF)

Mixed micellization/clouding assisted solubilization of polycyclic aromatic hydrocarbon: Potential in environmental remediation

Journal of molecular liquids, 2018-12, Vol.272, p.413-422

2018

Volltextzugriff (PDF)

An Experimental Study of Fabric Construction Using Minor Fibers for Sound Resistant Materials

Desai, Arpita

2020

Volltextzugriff (PDF)

Single-dose 177 Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

The lancet oncology, 2023-11, Vol.24 (11), p.1266

2023

Volltextzugriff (PDF)

Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

The lancet oncology, 2023-11, Vol.24 (11), p.1266-1276

2023

Volltextzugriff (PDF)

Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5032-5032

2023

Volltextzugriff (PDF)

Defining the prevalence of inherited DNA damage repair genetic variants (DDRv) in men with prostate cancer (PCa) detected by PSMA PET

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17010-e17010

2023

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(84)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy

Synthesis of Calix-Salen Silver Corates for Evaluation of Their Antimicrobial and Anticancer Activities

Differential treatment outcomes in BRCA1/2‐, CDK12‐, and ATM‐mutated metastatic castration‐resistant prostate cancer

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer

Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options

Synthesis of Novel Bis-imino and Bis-amino Curcuminoids for Evaluation of Their Anticancer and Antibacterial Activity

APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor

FGFR Signaling as a Target for Lung Cancer Therapy

Metal-free synthesis of calixsalen-type cavitands for the recognition of fluoride ion

Micellization and clouding behaviour of an ionic surfactant in a deep eutectic solvent: A case of the reline-water mixture

An interplay between spacer nature and alkyl chain length on aqueous micellar properties of cationic Gemini surfactants: A multi-technique approach

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors

Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment

Calix-salen cavitand as colorimetric chemosensor for Cu2+ and anticancer activity of copper cavitate

Mixed micellization/clouding assisted solubilization of polycyclic aromatic hydrocarbon: Potential in environmental remediation

An Experimental Study of Fabric Construction Using Minor Fibers for Sound Resistant Materials

Single-dose 177 Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial

Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging

Defining the prevalence of inherited DNA damage repair genetic variants (DDRv) in men with prostate cancer (PCa) detected by PSMA PET

Suchergebnisse filtern